BackContraFect Overview

ContraFect Long Term Debt

Latest long-term debt for CFRX: $1.9M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.87M
19.02% YoYΔ $-440000.00 vs prior year quarter

Peer average

Loading

ContraFect Long Term Debt History

Loading

ContraFect vs. peers: Long Term Debt Comparison

Loading

ContraFect Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ContraFect (CFRX) FAQ

ContraFect's long-term debt stands at $1.9M as of September 2023. That compares with $2.3M in the prior-year period — down 19.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

ContraFect reported $1.9M in long-term debt versus $2.3M a year earlier — a 19.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2.3M in the prior-year period — down 19.0% year over year. Sustained growth in long-term debt can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how ContraFect's long-term debt evolved across reporting periods, while the comparison chart places CFRX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, long-term debt is commonly used to spot outliers. ContraFect's reading of $1.9M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.